Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram and Sperm DNA Fragmentation in Healthy Men
NCT03527043Phase 2Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2017
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), generalized anxiety disorder (GAD), sponsored by Weill Cornell Medicine. Started Oct 2017; status: terminated.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
major depressive disorder (MDD)generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT03527043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03527043.